
Spectrum Pharmaceuticals SPPI
Spectrum Pharmaceuticals EV | SPPI
EV Jährlich Spectrum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 158 M | 80.8 M | 443 M | 325 M | 1.08 B | 1.74 B | 501 M | 360 M | 509 M | 568 M | 736 M | 718 M | 35.6 M | -82.3 M | -9.86 M |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.74 B | -82.3 M | 477 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Galectin Therapeutics
GALT
|
306 M | $ 2.68 | -4.63 % | $ 171 M | ||
|
Processa Pharmaceuticals
PCSA
|
837 K | $ 1.59 | -5.92 % | $ 2.08 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
3.82 B | $ 63.61 | -2.11 % | $ 6.61 B | ||
|
Progenity, Inc.
PROG
|
225 M | - | -3.47 % | $ 164 M | ||
|
Genprex
GNPX
|
-3.98 M | $ 1.46 | -12.87 % | $ 1.36 M | ||
|
Strongbridge Biopharma plc
SBBP
|
32.8 B | - | 1.52 % | $ 136 M | ||
|
Nektar Therapeutics
NKTR
|
1.27 B | $ 30.23 | -7.1 % | $ 510 M | ||
|
Innate Pharma S.A.
IPHA
|
98.2 M | $ 0.87 | -7.57 % | $ 77.9 M | ||
|
Seneca Biopharma, Inc.
SNCA
|
2.82 B | - | -1.19 % | $ 28.7 M | ||
|
BioMarin Pharmaceutical
BMRN
|
11.9 B | $ 60.42 | -1.64 % | $ 11.6 B | ||
|
Matinas BioPharma Holdings
MTNB
|
1.12 M | $ 0.75 | -9.23 % | $ 4.11 M | ||
|
Enanta Pharmaceuticals
ENTA
|
413 M | $ 7.6 | -4.82 % | $ 220 M | ||
|
Milestone Pharmaceuticals
MIST
|
143 M | $ 0.38 | -5.66 % | $ 40.4 M | ||
|
Lipocine
LPCN
|
15.2 M | $ 1.47 | -2.33 % | $ 8.01 M | ||
|
Seres Therapeutics
MCRB
|
110 M | $ 1.25 | -6.02 % | $ 11.1 M | ||
|
Oramed Pharmaceuticals
ORMP
|
91.5 M | $ 3.58 | -2.98 % | $ 148 M | ||
|
Madrigal Pharmaceuticals
MDGL
|
10.3 B | $ 378.19 | -4.68 % | $ 8.48 B | ||
|
CEL-SCI Corporation
CVM
|
21.1 M | $ 1.2 | -18.37 % | $ 9.62 M | ||
|
Inventiva S.A.
IVA
|
313 M | $ 3.14 | -9.13 % | $ 188 M | ||
|
MeiraGTx Holdings plc
MGTX
|
835 M | $ 7.98 | -1.97 % | $ 642 M | ||
|
Teva Pharmaceutical Industries Limited
TEVA
|
70.6 B | $ 39.21 | 1.76 % | $ 44.9 B | ||
|
Eton Pharmaceuticals
ETON
|
599 M | $ 60.77 | -0.96 % | $ 1.64 B | ||
|
IDEAYA Biosciences
IDYA
|
2.7 B | $ 25.52 | -2.48 % | $ 2.26 B | ||
|
Protalix BioTherapeutics
PLX
|
193 M | $ 2.89 | -5.56 % | $ 227 M | ||
|
Lantern Pharma
LTRN
|
13.6 M | $ 0.25 | -13.67 % | $ 2.72 M | ||
|
Foghorn Therapeutics
FHTX
|
582 M | $ 1.71 | -3.93 % | $ 108 M | ||
|
Ocugen
OCGN
|
652 M | $ 0.77 | 4.74 % | $ 241 M | ||
|
Oncolytics Biotech
ONCY
|
32.6 M | $ 0.35 | -10.37 % | $ 33.6 M | ||
|
Minerva Neurosciences
NERV
|
213 M | $ 2.03 | -4.25 % | $ 17.2 M | ||
|
Neurocrine Biosciences
NBIX
|
665 M | $ 150.5 | -3.89 % | $ 15 B | ||
|
Nanobiotix S.A.
NBTX
|
1.45 T | $ 26.12 | -1.7 % | $ 1.25 T | ||
|
Prothena Corporation plc
PRTA
|
-10.4 M | $ 8.12 | -3.33 % | $ 437 M | ||
|
Mereo BioPharma Group plc
MREO
|
2.03 B | $ 0.26 | -5.45 % | $ 207 M | ||
|
Maravai LifeSciences Holdings
MRVI
|
488 M | $ 6.99 | -2.85 % | $ 1.01 B | ||
|
Lexicon Pharmaceuticals
LXRX
|
635 M | $ 1.53 | -8.68 % | $ 555 M | ||
|
Moleculin Biotech
MBRX
|
706 K | $ 7.73 | -2.59 % | $ 9.16 M | ||
|
Takeda Pharmaceutical Company Limited
TAK
|
6.95 T | $ 21.79 | 1.66 % | $ 34.4 B | ||
|
Nurix Therapeutics
NRIX
|
1.47 B | $ 12.88 | -5.29 % | $ 1.12 B | ||
|
Nkarta
NKTX
|
210 M | $ 1.14 | 1.34 % | $ 84.3 M | ||
|
MacroGenics
MGNX
|
293 M | $ 1.97 | -0.76 % | $ 124 M | ||
|
Protagonist Therapeutics
PTGX
|
5.46 B | $ 121.72 | -2.2 % | $ 7.74 B | ||
|
Novo Nordisk A/S
NVO
|
541 B | $ 37.8 | -2.82 % | $ 168 B | ||
|
Marker Therapeutics
MRKR
|
6.72 M | $ 1.1 | -17.05 % | $ 16.8 M | ||
|
Arcus Biosciences
RCUS
|
1.95 B | $ 15.62 | -1.01 % | $ 1.68 B | ||
|
Replimune Group
REPL
|
997 M | $ 19.07 | -0.83 % | $ 1.77 B | ||
|
NextCure
NXTC
|
13.2 M | $ 6.62 | -2.43 % | $ 35.2 M | ||
|
Rocket Pharmaceuticals
RCKT
|
283 M | $ 1.95 | -7.82 % | $ 217 M | ||
|
PMV Pharmaceuticals
PMVP
|
59.5 M | $ 0.87 | -33.79 % | $ 45.7 M | ||
|
United Therapeutics Corporation
UTHR
|
22.8 B | $ 553.08 | -1.08 % | $ 24.5 B | ||
|
Olema Pharmaceuticals
OLMA
|
1.45 B | $ 7.0 | -2.1 % | $ 609 M |